Changes in the expression and distribution of claudins, increased epithelial apoptosis, and a mannan-binding lectin-associated immune response lead to barrier dysfunction in dextran sodium sulfate-induced rat colitis

Gut and Liver

Volumn 9, Issue 6, 2015, Pages 734-740

  Yuan, Bosi ^a   Zhou, Shuping ^b   Lu, Youke ^a   Liu, Jiong ^a   Jin, Xinxin ^a   Wan, Haijun ^a   Wang, Fangyu ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b Department of Gastroenterology and Hepatology   (China)

Author keywords

Apoptosis; Claudin; Colitis, ulcerative; Intestinal permeability; Mannan binding lectin associated serine proteases 2

Indexed keywords

CARBOHYDRATE; CLAUDIN; CLAUDIN 1; CLAUDIN 2; CLAUDIN 3; CLAUDIN 5; CLAUDIN 7; CLAUDIN 8; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DEXTRAN SULFATE; DNA NUCLEOTIDYLEXOTRANSFERASE; LACTULOSE; MANNAN BINDING LECTIN; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEASE 2; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNITOL; SUCRALOSE; UNCLASSIFIED DRUG; MANNOSE BINDING LECTIN; SUCROSE; TRICHLOROSUCROSE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DRUG EXCRETION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; STAINING; TUNEL ASSAY; URINE; URINE VOLUME; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; COLITIS; COLON; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; APOPTOSIS; CLAUDINS; COLITIS; COLON; DEXTRAN SULFATE; INTESTINAL MUCOSA; LACTULOSE; MANNITOL; MANNOSE-BINDING LECTIN; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SUCROSE; UP-REGULATION;

EID: 84935438267     PISSN: 19762283     EISSN: 20051212     Source Type: Journal    
DOI: 10.5009/gnl14155     Document Type: Article

References (42)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434.
2. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007;117:514-521.
3. Colombel JF, Watson AJ, Neurath MF. The 10 remaining mysteries of inflammatory bowel disease. Gut 2008;57:429-433.
4. Esaki M, Kubokura N, Kudo T, Matsumoto T. Endoscopic findings under narrow band imaging colonoscopy in ulcerative colitis. Dig Endosc 2011;23 Suppl 1:140-142.
5. Gilchrist KW, Harms BA, Starling JR. Abnormal rectal mucosa of the anal transitional zone in ulcerative colitis. Arch Surg 1995;130:981-983.
6. Salim SY, Söderholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis 2011;17:362-381.
7. Kiesslich R, Duckworth CA, Moussata D, et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 2012;61:1146-1153.
8. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004;286:C1213-C1228.
9. Furuse M, Hirase T, Itoh M, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993;123(6 Pt 2):1777-1788.
10. Furuse M, Sasaki H, Fujimoto K, Tsukita S. A single gene product, claudin-1 or-2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 1998;143:391-401.
11. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001;2:285-293.
12. Turksen K, Troy TC. Barriers built on claudins. J Cell Sci 2004; 117(Pt 12):2435-2447.
13. Mandell KJ, Parkos CA. The JAM family of proteins. Adv Drug Deliv Rev 2005;57:857-867.
14. Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 2008;1778:660-669.
15. Weber CR, Nalle SC, Tretiakova M, Rubin DT, Turner JR. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest 2008;88:1110-1120.
16. Zeissig S, Bürgel N, Günzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007; 56:61-72.
17. Prasad S, Mingrino R, Kaukinen K, et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest 2005;85:1139-1162.
18. Nielsen HL, Nielsen H, Ejlertsen T, et al. Oral and fecal Campylobacter concisus strains perturb barrier function by apoptosis induction in HT-29/B6 intestinal epithelial cells. PLoS One 2011;6: e23858.
19. Goretsky T, Dirisina R, Sinh P, et al. p53 mediates TNF-induced epithelial cell apoptosis in IBD. Am J Pathol 2012;181:1306-1315.
20. Liapis G, Boletis J, Skalioti C, et al. Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis. Histopathology 2013;63:649-658.
21. Cader MZ, Kaser A. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 2013; 62:1653-1664.
22. Degn SE, Jensen L, Hansen AG, et al. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function. J Immunol 2012;189: 3957-3969.
23. Héja D, Kocsis A, Dobó J, et al. Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc Natl Acad Sci U S A 2012;109:10498-10503.
24. Boniotto M, Braida L, Spanò A, et al. Variant mannose-binding lectin alleles are associated with celiac disease. Immunogenetics 2002;54:596-598.
25. Iltanen S, Mäki M, Collin P, et al. The association between mannan-binding lectin gene alleles and celiac disease. Am J Gastroenterol 2003;98:2808-2809.
26. Rector A, Lemey P, Laffut W, et al. Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease. Genes Immun 2001;2:323-328.
27. Grootjans J, Thuijls G, Verdam F, Derikx JP, Lenaerts K, Buurman WA. Non-invasive assessment of barrier integrity and function of the human gut. World J Gastrointest Surg 2010;2:61-69.
28. Yan Y, Kolachala V, Dalmasso G, et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS One 2009;4:e6073.
29. Perše M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012;2012:718617.
30. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. Structure and function of claudins. Biochim Biophys Acta 2008; 1778:631-645.
31. Sonoda N, Furuse M, Sasaki H, et al. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: evidence for direct involvement of claudins in tight junction barrier. J Cell Biol 1999;147:195-204.
32. Yu AS, Enck AH, Lencer WI, Schneeberger EE. Claudin-8 expression in Madin-Darby canine kidney cells augments the paracellular barrier to cation permeation. J Biol Chem 2003;278:17350-17359.
33. Peterson LW, Artis D. Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol 2014;14:141-153.
34. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009;9:799-809.
35. Kagnoff MF. The intestinal epithelium is an integral component of a communications network. J Clin Invest 2014;124:2841-2843.
36. Rescigno M. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends Immunol 2011;32:256-264.
37. Catalioto RM, Maggi CA, Giuliani S. Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions. Curr Med Chem 2011;18:398-426.
38. Su L, Shen L, Clayburgh DR, et al. Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis. Gastroenterology 2009;136: 551-563.
39. Turner MW. Mannose-binding lectin (MBL) in health and disease. Immunobiology 1998;199:327-339.
40. Garred P, Madsen HO, Hofmann B, Svejgaard A. Increased frequency of homozygosity of abnormal mannan-binding-protein alleles in patients with suspected immunodeficiency. Lancet 1995; 346:941-943.
41. Kovacs M, Papp M, Lakatos PL, et al. Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease. J Crohns Colitis 2013;7:134-141.
42. Hart ML, Ceonzo KA, Shaffer LA, et al. Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q. J Immunol 2005;174:6373-6380.